INTERNATIONAL PATENT: SLING THERAPEUTICS, INC., HAMMER, GARY, DOUGLAS FILES APPLICATION FOR "USE OF INHIBITORS OF INSULIN-LIKE GROWTH FACTOR RECEPTOR-1 FOR OCULAR-ASSOCIATED DISORDERS"

GENEVA, July 30 -- SLING THERAPEUTICS, INC. (455 E. Eisenhower Pkwy., Suite 300 PMB 1048Ann Arbor, MI 48108), HAMMER, Gary, Douglas (c/o Sling Therapeutics, Inc.455 E. Eisenhower Pkwy., Suite 300 PMB 1048Ann Arbor, MI 48108) filed a patent application (PCT/US2025/012149) for "USE OF INHIBITORS OF INSULIN-LIKE GROWTH FACTOR RECEPTOR-1 FOR OCULAR-ASSOCIATED DISORDERS" on Jan 17, 2025. With publication no. WO/2025/155888, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SLING THERAPEUTICS, INC. (455 E. Eisenhower Pkwy., Suite...